et al.
et al.
et al.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
precision and efficiency. To investigate the specificity<br />
of RNA-guided genome modification,<br />
we an<strong>al</strong>yzed single-nucleotide mismatches b<strong>et</strong>ween<br />
the spacer and its mamm<strong>al</strong>ian protospacer<br />
targ<strong>et</strong> (Fig. 3A). We observed that single-base<br />
mismatch up to 11 bp 5′ of the PAM compl<strong>et</strong>ely<br />
abolished genomic cleavage by SpCas9, whereas<br />
spacers with mutations farther upstream r<strong>et</strong>ained<br />
activity against the protospacer targ<strong>et</strong> (Fig. 3B).<br />
A<br />
B<br />
human<br />
EMX1<br />
locus<br />
pre-crRNA<br />
tracrRNA<br />
protospacer (1)<br />
pre-crRNA + tracrRNA processing<br />
spacer (30 bp)<br />
chimeric RNA<br />
guide sequence (20 bp)<br />
Fig. 2. SpCas9 can be reprogrammed to targ<strong>et</strong> multiple genomic loci in<br />
mamm<strong>al</strong>ian cells. (A) Schematic of the human EMX1 locus showing the<br />
location of five protospacers indicated by blue lines with corresponding<br />
PAM in magenta. (B) Schematic of the pre-crRNA:tracrRNA complex (top)<br />
showing hybridization b<strong>et</strong>ween the direct repeat (gray) region of the precrRNA<br />
and tracrRNA. Schematic of a chimeric RNA design (12) (bottom).<br />
A<br />
human EMX1<br />
locus<br />
C<br />
wt crRNA<br />
mismatchcontaining<br />
guide<br />
sequences<br />
human<br />
EMX1<br />
locus<br />
left TALEN binding site<br />
protospacer (1)<br />
protospacer (1)<br />
This is consistent with previous bacteri<strong>al</strong> and in<br />
vitro studies of Cas9 specificity (12, 20). Furthermore,<br />
SpCas9 is able to mediate genomic cleavage<br />
as efficiently as a pair of TALE nucleases<br />
(TALENs) targ<strong>et</strong>ing the same EMX1 protospacer<br />
(Fig.3,CandD).<br />
Targ<strong>et</strong>ed modification of genomes ide<strong>al</strong>ly<br />
avoids mutations arising from the error-prone<br />
NHEJ mechanism. The wild-type SpCas9 is able<br />
PAM<br />
PAM<br />
right TALEN binding site<br />
Fig. 3. Ev<strong>al</strong>uation of the SpCas9 specificity and comparison of efficiency<br />
with TALENs. (A) EMX1-targ<strong>et</strong>ing chimeric crRNAs with single point mutations<br />
were generated to ev<strong>al</strong>uate the effects of spacer-protospacer mismatches. (B)<br />
protospacer (5)<br />
C EMX1<br />
protospacer<br />
targ<strong>et</strong><br />
to mediate site-specific DSBs, which can be repaired<br />
through either NHEJ or homology-directed<br />
repair (HDR). We engineered an aspartate-to<strong>al</strong>anine<br />
substitution (D10A) in the RuvC I domain<br />
of SpCas9 to convert the nuclease into a<br />
DNA nickase (SpCas9n, Fig. 4A) (12, 13, 20),<br />
because nicked genomic DNA is typic<strong>al</strong>ly repaired<br />
either seamlessly or through high-fidelity<br />
HDR. SURVEYOR (Fig. 4B) and sequencing of<br />
protospacer (4)<br />
protospacer (2)<br />
protospacer (3)<br />
tracrRNA sequence is shown in red and the 20-bp spacer sequence in<br />
blue. (C) SURVEYOR assay comparing the efficacy of Cas9-mediated<br />
cleavage at five protospacers in the human EMX1 locus. Each protospacer<br />
was targ<strong>et</strong>ed by using either processed pre-crRNA:tracrRNA complex (crRNA)<br />
or chimeric RNA (chiRNA). Arrowheads indicate cleavage products for<br />
each protospacer targ<strong>et</strong>.<br />
B<br />
684bp<br />
367bp<br />
317bp<br />
indel (%)<br />
indel (%)<br />
chimeric RNA with mismatched guide sequence<br />
2kb<br />
m17<br />
m15<br />
m13<br />
m11<br />
m9<br />
m7<br />
m5<br />
m4<br />
m3<br />
m2<br />
m1<br />
wt<br />
5.6 7.5 8.8 9.7<br />
D TALEN chimeric RNA crRNA control<br />
684bp<br />
367bp<br />
317bp<br />
3.6 3.8 4.5 11 7.4 8.6 22 29 25<br />
REPORTS<br />
SURVEYOR assay comparing the cleavage efficiency of different mutant chimeric<br />
RNAs. (C) Schematic showing the design of TALENs that targ<strong>et</strong> EMX1.<br />
(D) SURVEYOR gel comparing the efficiency of TALEN and SpCas9 (N =3).<br />
www.sciencemag.org SCIENCE VOL 339 15 FEBRUARY 2013 821<br />
on February 14, 2013<br />
www.sciencemag.org<br />
Downloaded from